Objective: To probe into the pharmaceutical care developed by clinical pharmacists in the department of nephrology. Methods: Clinical pharmacists participated into the treatment process of catheter-related bloodstream infection in two children

suggested the clinicians to choose the appropriate drugs according to children’s disease

adjusted the dosage according to the hemodialysis status and provided pharmaceutical care. Results: Clinical pharmacists participated into the clinical treatment of catheter-related bloodstream infection in children with intermittent hemodialysis from nephrology department

two children were treated well

no adverse drug reactions were observed

and two children were improved and discharged. Conclusion: The active participation of clinical pharmacists in the treatment of children with intermittent hemodialysis can ensure safer and more rational use of drugs in clinical practice.